Chen et al. found that long-term use of estrogen-deprivation drugs in a breast cancer study led to metabolic re-editing of breast cancer cells, which caused an up-regulation of Dio3os expression to promote cancer cell proliferation by increasing glycolysis [20]. The gene discussed is DIO3OS; the disease is breast cancer.